Regulation 2(1)

SCHEDULE 2 N.I. MUTUAL RECOGNITION AGREEMENTS

Extent Information

E1 This version of this provision extends to Northern Ireland only; a separate version has been created for England and Wales and Scotland only for the substitution of Sch. 2 in relation to E.W.S. (31.12.2020) by The Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/791), regs. 1(1), 9(10) (as amended by S.I. 2020/1478, regs. 1(3), Sch. 2 para. 2); 2020 c. 1, Sch. 5 para. 1(1)

1.  The agreement on mutual recognition in relation to conformity assessment certificates and markings between the European Community and Australia, initialled on 19th July 1996 M1 . N.I.

Marginal Citations

M1 OJ No. L 229, 17.8.1998, p.3.

2.  The agreement on mutual recognition in relation to conformity assessment between the European Union and New Zealand, initialled on 19th July 1996 M2 . N.I.

Marginal Citations

M2 OJ No. L 229, 17.8.1998, p.62.

3.  The agreement on mutual recognition between the European Community and Canada, signed in London on 14th May 1998 M3 . N.I.

Marginal Citations

M3 OJ No. L 280, 16.10.1998, p.3.

4.  The agreement on mutual recognition between the European Community and the United States of America, signed in London on 18th May 1998 M4 . N.I.

Marginal Citations

M4 OJ No. L 31, 4.2.1999, p.3.

[F1 5.   The agreement between the European Community and the Swiss Confederation on mutual recognition in relation to conformity assessment signed in Luxembourg on 21st June 1999.] U.K.

Textual Amendments

F1 Sch. 2 para. 5 added (21.10.2013) by The Medical Devices (Amendment) Regulations 2013 (S.I. 2013/2327), regs. 1(2), 20